Your browser doesn't support javascript.
Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection.
Jiang, Xiao-Lin; Zhu, Ka-Li; Wang, Xue-Jun; Wang, Guo-Lin; Li, Yi-Ke; He, Xue-Juan; Sun, Wen-Kui; Huang, Peng-Xiang; Zhang, Jin-Zhong; Gao, Hui-Xia; Dai, Er-Hei; Ma, Mai-Juan.
  • Jiang XL; Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
  • Zhu KL; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China.
  • Wang XJ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China; Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.
  • Wang GL; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.
  • Li YK; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China; Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.
  • He XJ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China; Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.
  • Sun WK; Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
  • Huang PX; Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
  • Zhang JZ; Department of Infectious Disease Control and Prevention, Liaocheng Center for Disease Control and Prevention, Liaocheng, China.
  • Gao HX; Department of Laboratory Medicine, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China.
  • Dai EH; Department of Laboratory Medicine, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China.
  • Ma MJ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China; Department of Epidemiology, School of Public Health, Zhengzhou U
Lancet Infect Dis ; 23(1): 28-30, 2023 01.
Article in English | MEDLINE | ID: covidwho-2170700
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Breakthrough Infections / Antibodies, Viral Topics: Vaccines / Variants Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2023 Document Type: Article Affiliation country: S1473-3099(22)00805-2

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Breakthrough Infections / Antibodies, Viral Topics: Vaccines / Variants Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2023 Document Type: Article Affiliation country: S1473-3099(22)00805-2